跳至主要内容
临床试验/NL-OMON27475
NL-OMON27475招募中不适用

Pamidronate for Pain in Sternocostoclavicular Hyperostosis: a double-blind randomized placebo-controlled trial

eiden University Medical Center0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult patients with an established diagnosis of SCCH based on clinical and radiologic features and increased radioactive tracer uptake on 99mTc scan
  • - Reported maximum pain score of 6/10 or higher
  • - No treatment with bisphosphonates for the previous 6 months

排除标准

  • - Patients under 18 years of age
  • - Active pregnancy wish, pregnancy or nursing
  • - Generalized pain without SCCH related pain
  • - Bisphosphonate use 6 months before study entry
  • - Bisphosphonate allergy
  • - Estimated glomerular filtration rate < 30 ml/min
  • - Uncontrolled endocrine abnormalities
  • - Active cancer treatment
  • - Language barrier, severe co-morbidity, mental disability, poor mobility and other causes preventing attendance for control visits, In case of poor dental hygiene or inadequate dental care, patients will only be enrolled after oral maxillary surgeon consultation.

研究者

发起方
eiden University Medical Center

相似试验